Latest news salmeterol

FDA clears path for leadership Advair generics Advair (fluticasone and salmeterol) has already begun to lose patent protection in some markets, incl...


FDA clears path for leadership Advair generics
Advair (fluticasone and salmeterol) has already begun to lose patent protection in some markets, including the U.S. in 2010, but it remains an important product for GSK. The revenues of about $ 7.6 billion last year on the approved indications in asthma and Advair …
Read more at

Leave a Reply